Your browser doesn't support javascript.
loading
Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis.
Domingo-Gonzalez, Racquel; Das, Shibali; Griffiths, Kristin L; Ahmed, Mushtaq; Bambouskova, Monika; Gopal, Radha; Gondi, Suhas; Muñoz-Torrico, Marcela; Salazar-Lezama, Miguel A; Cruz-Lagunas, Alfredo; Jiménez-Álvarez, Luis; Ramirez-Martinez, Gustavo; Espinosa-Soto, Ramón; Sultana, Tamanna; Lyons-Weiler, James; Reinhart, Todd A; Arcos, Jesus; de la Luz Garcia-Hernandez, Maria; Mastrangelo, Michael A; Al-Hammadi, Noor; Townsend, Reid; Balada-Llasat, Joan-Miquel; Torrelles, Jordi B; Kaplan, Gilla; Horne, William; Kolls, Jay K; Artyomov, Maxim N; Rangel-Moreno, Javier; Zúñiga, Joaquín; Khader, Shabaana A.
Afiliación
  • Domingo-Gonzalez R; Department of Molecular Microbiology and.
  • Das S; Department of Molecular Microbiology and.
  • Griffiths KL; Department of Molecular Microbiology and.
  • Ahmed M; Department of Molecular Microbiology and.
  • Bambouskova M; Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Gopal R; Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Gondi S; Department of Molecular Microbiology and.
  • Muñoz-Torrico M; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Salazar-Lezama MA; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Cruz-Lagunas A; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Jiménez-Álvarez L; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Ramirez-Martinez G; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Espinosa-Soto R; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Sultana T; Bioinformatics Analysis Core, Genomics and Proteomics Core Laboratories, and.
  • Lyons-Weiler J; Bioinformatics Analysis Core, Genomics and Proteomics Core Laboratories, and.
  • Reinhart TA; Department of Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Arcos J; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • de la Luz Garcia-Hernandez M; Cardiovascular Research Institute, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Mastrangelo MA; Cardiovascular Research Institute, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Al-Hammadi N; Division of Biostatistics and.
  • Townsend R; Proteomics Shared Resource, Washington University in St. Louis, St. Louis, Missouri, USA.
  • Balada-Llasat JM; Department of Pathology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
  • Torrelles JB; Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
  • Kaplan G; Public Health Research Institute Center, New Jersey Medical School-Rutgers, State University of New Jersey, Newark, New Jersey, USA.
  • Horne W; Richard King Mellon Institute for Pediatric Research, Department of Pediatrics and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Kolls JK; Richard King Mellon Institute for Pediatric Research, Department of Pediatrics and Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Artyomov MN; Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Rangel-Moreno J; Division of Allergy, Immunology and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA.
  • Zúñiga J; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.
  • Khader SA; Department of Molecular Microbiology and.
JCI Insight ; 2(19)2017 10 05.
Article en En | MEDLINE | ID: mdl-28978810
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Interleucina-17 / Subunidad alfa del Factor 1 Inducible por Hipoxia / Granuloma Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Interleucina-17 / Subunidad alfa del Factor 1 Inducible por Hipoxia / Granuloma Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2017 Tipo del documento: Article